Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FSZ31
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,663
Award facts
- Contract value 100% obligated
- $16,663.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $16,663.44 by the Defense Logistics Agency (DLA) for Nexplanon 68 mg implants. This firm fixed-price delivery order, issued on August 21, 2025, is set to be completed by September 12, 2025. The award represents a task order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $499.999 billion vehicle that enables the agency to procure a comprehensive range of pharmaceutical products supporting Department of Defense healthcare facilities worldwide.
The delivery order supports the DLA's ongoing pharmaceutical supply chain operations, which provide medical products to military health facilities across the globe. Nexplanon implants are a contraceptive medical device that falls within the broad scope of the parent IDC agreement. As a woman-owned small business, DMS Pharmaceutical Group competes effectively in federal procurement markets and has established itself as a critical supplier in the federal pharmaceutical distribution network. The company's extensive federal contract portfolio demonstrates consistent capability in delivering specialized pharmaceutical products, branded and generic prescription drugs, biologics, and medical consumables to government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FSZ31?
SPE2DB25FSZ31 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 21, 2025.
How much is contract SPE2DB25FSZ31 worth?
The government has obligated $16,663 on SPE2DB25FSZ31.
Is contract SPE2DB25FSZ31 an order under another contract?
Yes. SPE2DB25FSZ31 is a delivery order under SPE2DB22D9367, an indefinite delivery contract.
Was contract SPE2DB25FSZ31 competed?
The extent of competition for SPE2DB25FSZ31 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award